 |
ID#: FCA-1015 |
OTC Stress Relief Product
|
| Business Synopsis: |
| Projected Revenue: |
$124,800,000 |
Location: |
Southwestern Region |
| Projected EBITDA: |
$97,372,600 |
Revenue & EBITDA (in Millions):
 |
Acquistion Highlights:
- Experienced Consultants
- Lucrative Profit Margins
- Turn Key Operation
- Strong Competitive Advantage
- FDA compliance(DSHEA)
- Successful initial launch
- Attractive packaging
- Proven Marketing Plan
- No Direct Compeititors
- Only product of its kind
- Multiple products delivery system
|
Business Synopsis: |
Balance Sheet: |
| Established In: |
2005 |
Current Assets: |
$0 |
| Employees: |
4 Total |
Fixed Assets: |
$500,000 |
| Facilities: |
Leased Facilities |
Total Assets: |
$500,000 |
| Business Format: |
Private Corporation |
Total Liabilities: |
$0 |
| Exit Strategy : |
RTO/IPO |
Shareholder Equity: |
$500,000 |
|
|
Actual Product Packaging Mock-up:
 |
Eagleaf Disclaimer: This site makes no representations, and specifically disclaims all warranties, express, implied or statutory, regarding the accuracy, timeliness, completeness, merchantability, or fitness for any particular purpose of any material contained on this site. Eagleaf does not warrant that the information on our Website will be accurate, complete, uninterrupted or error-free, or that defects will be corrected. The information contained herein does not suggest or imply and should not be construed, in any manner, a guarantee of future performance and / or investment advice. There is no implied or expressed warranties on the information and materials in this site. The information and materials are provided "as is". Eagleaf and its employees specifically disclaim any liability, loss, or risk, personal or otherwise, incurred directly or indirectly as a consequence of the use and application of any information on this Website. Use of this service is at your own risk.